Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain

Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain

Sushruta S Hakkimane,1 Vishnu Prasad Shenoy,2 Santosh L Gaonkar,3 Indira Bairy,4 Bharath Raja Guru1,5 1Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India; 2Department of Microbiology, Kasturba Medical College, Manipal Academy o...

Full description

Bibliographic Details
Main Authors:	Hakkimane SS, Shenoy VP, Gaonkar SL, Bairy I, Guru BR
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-07-01
Series:	International Journal of Nanomedicine
Subjects:	Rifampicin nanoparticles Improved Isoniazid nanoparticles antimicrobial susceptibility Mycobacterium tuberculosis Minimum Inhibitory Concentration
Online Access:	https://www.dovepress.com/antimycobacterial-susceptibility-evaluation-of-rifampicin-and-isoniazi-peer-reviewed-article-IJN

Similar Items

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
by: Elias Adikwu, et al.
Published: (2020-01-01)

Nephroprotective Effects of Ficus religiosa Linn (Peepal Plant) Stem Bark against Isoniazid and Rifampicin Induced nephrotoxicity in Albino Rabbits
by: Nadia Hashmi1, Faqir Muhammad1*, Ijaz Javed1, Junaid Ali Khan1, Muhammad Zargham Khan2, Tanweer Khaliq1 and Bilal Aslam1
Published: (2013-07-01)

Hepatoprotective activity of melittin on isoniazid- and rifampicin-induced liver injuries in male albino rats
by: Khalid Mohammed Naji, et al.
Published: (2021-07-01)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates
by: M Hamze, et al.
Published: (2015-01-01)

Structure and function of the liver in conditions of chrome-isoniazid-rifampicin affection of rats after applying of sorbex
by: N. I. Burmas, et al.
Published: (2014-09-01)

Protective Effects of Solanium Nigrum Methanolic Extract Against Isoniazid/Rifampicin Induced Hepatotoxicity in Rats
by: Abdel-Hameed M.Fayed, et al.
Published: (2019-10-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

Oral pyridoxine can substitute for intravenous pyridoxine in managing patients with severe poisoning with isoniazid and rifampicin fixed dose combination tablets: a case report
by: M. D. S. A. Dilrukshi, et al.
Published: (2017-08-01)

Amelioration of isoniazid and rifampicin-induced liver toxicity by Amaranthus graecizans subsp. silvestris in rat
by: Saiqa Ishtiaq, et al.
Published: (2017-09-01)

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
by: A. K. Hemanth Kumar, et al.
Published: (2018-01-01)

Transdermal delivery of isoniazid and rifampicin by pheroid technology / Adèle Botes
by: Botes, Adèle
Published: (2009)

Transdermal delivery of isoniazid and rifampicin by pheroid technology / Adèle Botes
by: Botes, Adèle
Published: (2009)

Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics
by: Ana Santoveña-Estévez, et al.
Published: (2020-02-01)

Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis
by: Saba Kabir, et al.
Published: (2021-02-01)

Improved Stability of Rifampicin in the Presence of Gastric-Resistant Isoniazid Microspheres in Acidic Media
by: Chiluba Mwila, et al.
Published: (2020-03-01)

Hepatoprotective Effect of Citrus Sinensis Peel Extract Against Isoniazid and Rifampicin-induced Liver Injury in Wistar Rats
by: Edward Kosasih, et al.
Published: (2019-12-01)

Evaluation of FluoroType MTB for direct detection of Mycobacterium tuberculosis complex and GenoType MTBDRplus for determining rifampicin and isoniazid resistance
by: Gonca Erkose Genc, et al.
Published: (2018-07-01)

Antimycobacterial Activities of an Edible Mushroom Extract and its Synergy with the Standard Antituberculous Drugs
by: Debasmita Chatterjee, et al.
Published: (2018-06-01)

A new rapid colourimetric method for testing Mycobacterium tuberculosis susceptibility to isoniazid and rifampicin: a crystal violet decolourisation assay
by: Ahmet Yilmaz Coban
Published: (2014-04-01)

Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and Rifampicin
by: A. A. Kachanova, et al.
Published: (2021-03-01)

PREVALENCE AND RISK FACTORS OF MULTI DRUG RESISTANT TUBERCULOSISAMONG REFUGEES IN THE RESETTLEMENTCAMPS OF ADJUMANI, MOYO AND YUMBE DISTRICTSWEST NILE REGION
by: Laurent Nshizirungu, et al.
Published: (2020-12-01)

Development and validation of an electroanalytical methodology for determination of isoniazid and rifampicin content in pharmaceutical formulations
by: Katia Christina Leandro, et al.
Published: (2009-06-01)

Influence of isoniazid on the metabolism of rifampicin on rat hepatocytes
by: Fasich Fasich, et al.
Published: (2000-06-01)

Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh
by: Kostera J, et al.
Published: (2018-05-01)

Design of Mannose-Coated Rifampicin nanoparticles modulating the immune response and Rifampicin induced hepatotoxicity with improved oral drug delivery
by: Aisha Rauf, et al.
Published: (2021-09-01)

Nanoparticle-Based Rifampicin Delivery System Development
by: Marjan Motiei, et al.
Published: (2021-04-01)

Rifampicin-Loaded Mesoporous Silica Nanoparticles for the Treatment of Intracellular Infections
by: Santhni Subramaniam, et al.
Published: (2019-04-01)

A comparative study on the adverse effects of two anti-tuberculosis drugs regimen in initial two-month treatment period
by: Begum Lutfun Nahar, A.K.M. Mosharrof Hossain, M. Monirul Islam and Dipti Rani Saha
Published: (2006-12-01)

Metabolomic Study to Determine the Mechanism Underlying the Effects of <i>Sagittaria sagittifolia</i> Polysaccharide on Isoniazid- and Rifampicin-Induced Hepatotoxicity in Mice
by: Xiu-Hui Ke, et al.
Published: (2018-11-01)

The solubility enhancement and the stability assessment of rifampicin, isoniazid and pyrazinamide in aqueous media
by: Chen, Yu-Jen
Published: (2000)

Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using three months of isoniazid and rifampicin
by: Mathivha, Khakhu Tshilidzi
Published: (2016)

Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
by: Ronald Anderson, et al.
Published: (2018-11-01)

Ameliorative effect of Leucas cephalotes extract on isoniazid and rifampicin induced hepatotoxicity
by: Bhini Bais, et al.
Published: (2014-07-01)

NANOBIOCATALYTIC SYSTEMS BASED ON LIPASE-Fe3O4 AND CONVENTIONAL SYSTEMS FOR ISONIAZID SYNTHESIS: A COMPARATIVE STUDY
by: V. M. Costa, et al.

Early Detection of Multi-drug Resistant Tuberculosis and Mutations in Mycobacterium tuberculosis isolates using Line Probe Assay from a Tertiary Care Centre in Northern India
by: Omar Rashid, et al.
Published: (2020-06-01)

Detection of multidrug resistant Mycobacterium tuberculosis in Tabuk, Saudi Arabia, using Genotype MTBDRplus
by: Eltayib Hassan Ahmed-Abakur, et al.
Published: (2019-01-01)

Hyperglycaemia induced by isoniazid preventive therapy
by: Roshni Jhan Ganguly, et al.
Published: (2018-01-01)

Mecanismos de acción y de resistencia a rifampicina e isoniacida en Mycobacterium tuberculosis: nueva información sobre viejos conocidos Mechanisms of action of and resistance to rifampicin and isoniazid in Mycobacterium tuberculosis: new information on old friends
by: A. I. De la Iglesia, et al.
Published: (2006-04-01)